Mechanisms of B cell receptor activation and responses to B cell receptor inhibitors in B cell malignancies

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - mdpi.com
The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a
number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse …

Targeting the B cell receptor pathway in non-Hodgkin lymphoma

K Valla, CR Flowers, JL Koff - Expert opinion on investigational …, 2018 - Taylor & Francis
Introduction: Dysregulated B cell receptor (BCR) signaling has been identified as a potent
contributor to tumor survival in B cell non-Hodgkin lymphomas (NHLs). This pathway's …

Regulation of B-cell receptor signaling and its therapeutic relevance in aggressive B-cell lymphomas

N Profitós-Pelejà, JC Santos, A Marín-Niebla, G Roué… - Cancers, 2022 - mdpi.com
Simple Summary Dysregulated B-cell receptor (BCR) signaling is considered a potent
contributor to tumor survival in different subtypes of B-cell non-Hodgkin lymphomas (B …

Targeting pathological B cell receptor signalling in lymphoid malignancies

RM Young, LM Staudt - Nature reviews Drug discovery, 2013 - nature.com
Signalling through the B cell receptor (BCR) is central to the development and maintenance
of B cells. In light of the numerous proliferative and survival pathways activated downstream …

B‐cell receptor signalling and its crosstalk with other pathways in normal and malignant cells

V Seda, M Mraz - European journal of haematology, 2015 - Wiley Online Library
The physiology of B cells is intimately connected with the function of their B‐cell receptor
(BCR). B‐cell lymphomas frequently (dys) regulate BCR signalling and thus take advantage …

B-cell receptor signaling in the pathogenesis of lymphoid malignancies

K Bojarczuk, M Bobrowicz, M Dwojak, N Miazek… - Blood Cells, Molecules …, 2015 - Elsevier
B-cell receptor (BCR) signaling pathway plays a central role in B-lymphocyte development
and initiation of humoral immunity. Recently, BCR signaling pathway has been shown as a …

Targeting the B-cell receptor signaling pathway in B lymphoid malignancies

M Buchner, M Müschen - Current opinion in hematology, 2014 - journals.lww.com
Targeting of the B-cell receptor tyrosine kinases spleen tyrosine kinase, Bruton's tyrosine
kinase, and phosphatidylinositol 3-kinase achieve promising clinical responses in various …

Targeting B-cell receptor signaling: changing the paradigm

N Fowler, E Davis - Hematology 2013, the American Society of …, 2013 - ashpublications.org
It is well known that signals emanating from the B-cell receptor (BCR) activate downstream
pathways to regulate the development and survival of normal B cells. In B-cell malignancies …

New insights into pre-BCR and BCR signalling with relevance to B cell malignancies

RC Rickert - Nature Reviews Immunology, 2013 - nature.com
The B cell receptor (BCR) and its precursor (pre-BCR) control B cell homeostasis,
differentiation and function. Moreover, aberrant pre-BCR and BCR signalling have a central …

Inhibitors of B-cell receptor signaling for patients with B-cell malignancies

MY Choi, TJ Kipps - The Cancer Journal, 2012 - journals.lww.com
The B-cell receptor (BCR) complex and its associated protein tyrosine kinases play a critical
role in the development, proliferation, and survival of normal or malignant B cells. Regulated …